Schubert & CO Takeda Pharmaceutical CO LTD Transaction History

Schubert & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$15.28 - $16.48 $458 - $494	-30 Reduced 7.16%	389 $6,000
Q4 2022 Jan 31, 2023	SELL	$12.42 - $15.62 $3,254 - $4,092	-262 Reduced 38.47%	419 $6,000
Q3 2022 Oct 21, 2022	BUY	$12.8 - $28.65 $1,395 - $3,122	109 Added 19.06%	681 $9,000
Q2 2022 Aug 01, 2022	BUY	$13.12 - $15.03 $7,504 - $8,597	572 New	572 $8,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.